| 中文名称 | 英文名称 | CAS号 | 化学式 |
|---|---|---|---|
| PVM/MA共聚物乙酯 | Gantrez ES 225 | 25087-06-3 | C9H14O5 |
| PVM/MA共聚物 | vorasidenib | 1644545-52-7 | C14H13ClF6N6 |
| PTP抑制剂IV | C,C,C-Trifluoro-N-[4-(1-methyl-1-{4-[1-methyl-1-(4-trifluoromethanesulfonylamino-phenyl)-ethyl]-phenyl}-ethyl)-phenyl]-methanesulfonamide | 329317-98-8 | C26H26F6N2O4S2 |
| PTH-天冬酰胺 | D,L-asparagine N-phenylthiohydantoin | 5624-08-8 | C11H11N3O2S |
| PTH-DL-α-氨基异丁酸 | 5,5-Dimethyl-3-phenyl-2-thiohydantoin | 21083-30-7 | C11H12N2OS |
| PTH-DL-2-氨基丁酸 | 5-ethyl-3-phenyl-2-thioxoimidazolidin-4-one | 66256-32-4 | C11H12N2OS |
| PTCBI(顺反混合物) | Benzimidazole perylene | 79534-91-1 | C27H18N2 |
| PTC-209抑制剂 | PTC-209 | 315704-66-6 | C17H13Br2N5OS |
| PSS-联苯基乙烯基硅氧基-七环戊基取代物 | Pss-(diphenylvinylsilyloxy)heptaclopent& | 312693-49-5 | C49H76O13Si9 |
| PSS-甲苯基乙烯基硅氧基-七环戊基取代物 | Pss-methylphenylvinylsilyloxy-heptacycl& | 312693-48-4 | C44H74O13Si9 |
| PSS-烯丙基-七环戊基取代 | PSS-Allyl-Heptacyclopentyl substituted | 205131-81-3 | C38H68O12Si8 |
| PSS-烯丙基-七异丁基取代 | PSS-Allyl-Heptaisobutyl substituted | 351003-00-4 | C31H68O12Si8 |
| PSS-氯丙基-异丁基取代 | (3-chloropropyl)hepta(isobutyl)octasilsesquioxane | 480438-84-4 | C31H69ClO12Si8 |
| PSS-八[2-(氯二甲基硅烷基)乙基]取代 | octa(chlorodimethylsilylethyl)silsesquioxane | 243146-51-2 | C32H80Cl8O12Si16 |
| PSS-八(2-二氯甲基硅基乙基)取代 | 1,3,5,7,11,13,15-octakis[2-(dichloromethylsilyl)ethyl]pentacyclo[9.5.1.1<sup>3,9</sup>.1<sup>5,15</sup>.1<sup>7,13</sup>]octasiloxane | 314727-18-9 | C24H56Cl16O12Si16 |
| PSS-[2-(3-环己烯)乙基]-七环戊基取代 | Pss-(2-(3-cyclohexen-1-YL)ethyl)heptacy& | 307496-19-1 | C43H76O12Si8 |
| PSS-[2-(3,4-环氧环己基)乙基]-取代七异丁基 | 1,3,5,7,9,11,13-Heptakis(2-methylpropyl)-15-[2-(7-oxabicyclo[4.1.0]heptan-3-yl)ethyl]-2,4,6,8,10,12,14,16,17,18,19,20-dodecaoxa-1,3,5,7,9,11,13,15-octasilapentacyclo[9.5.1.13,9.15,15.17,13]icosane | 445379-56-6 | C36H76O13Si8 |
| PSS-[2-(3,4-环氧树脂环己基)乙基]-七环戊基取代 | 1,3,5,7,9,11,13-heptacyclopentyl-15-[2-(7-oxabicyclo[4.1.0]heptan-3-yl)ethyl]-2,4,6,8,10,12,14,16,17,18,19,20-dodecaoxa-1,3,5,7,9,11,13,15-octasilapentacyclo[9.5.1.13,9.15,15.17,13]icosane | 307496-16-8 | C43H76O13Si8 |
| PSS-[1-(乙基十一酸)]-七环戊基取代 | Pss-(1-(ethyl undecanoate))-heptacyclop& | 308103-65-3 | C48H88O14Si8 |
| PSS-Octa(2-三氯甲硅烷基乙基)取代 | 1,3,5,7,11,13,15-octakis[2-(trichlorosilyl)ethyl]pentacyclo[9.5.1.1<sup>3,9</sup>.1<sup>5,15</sup>.1<sup>7,13</sup>]octasiloxane | 214675-88-4 | C16H32Cl24O12Si16 |
| PSS-(4-(氯甲基)苯基)-七环戊基取代 | Pss-(4-(chloromethyl)phenyl))-heptacycl& | 307496-35-1 | C42H69ClO12Si8 |
| PSS-(3-缩水甘油基)丙氧基-取代七异丁基 | Pss-(3-glycidyl)propoxy-heptaisobutyl S& | 444315-17-7 | C34H74O14Si8 |
| PSS-(3-环己基)-七环戊基取代 | Pss-(3-cyclohexen-1-YL)-heptacyclopenty& | 307496-29-3 | C41H72O12Si8 |
| PSS-(3-巯基)丙基-七异丁基取代 | 1-(3-mercapto)propyl-3,5,7,9,11,13,15-isobutylpentacyclo[9.5.1.1<sup>3,9</sup>.1<sup>5,15</sup>.1<sup>7,13</sup>]octasiloxane | 480438-85-5 | C31H70O12SSi8 |
| PSS-(2-(反式-3,4-环己二醇)乙基)-七异丁基取代 | Pss-(2-(trans-3 4-cyclohexanediol)ethyl& | 480439-48-3 | C36H78O14Si8 |
| PSS-(1-丙基异丁烯酸)-七异丁基取代 | Pss-(1-propylmethacrylate)-heptaisobuty& | 307531-94-8 | C35H74O14Si8 |
| PSS-(1-(甲基丙酸))-七环戊基取代 | methyl 3-(3,5,7,9,11,13,15-heptacyclopentyl-2,4,6,8,10,12,14,16,17,18,19,20-dodecaoxa-1,3,5,7,9,11,13,15-octasilapentacyclo[9.5.1.13,9.15,15.17,13]icosan-1-yl)propanoate | 308103-64-2 | C39H70O14Si8 |
| PSN375963盐酸盐 | PSN375963 | 388575-52-8 | C17H23N3O |
| PRT-060318(PRT318)中间体 | 2-chloro-4-(3-methylanilino)pyrimidine-5-carboxylic acid | 227449-26-5 | C12H10ClN3O2 |
| PROTOPORPHYRIN營XCOBALTCHLORIDE | Co(iii) protoporphyrin ix chloride | 102601-60-5 | C34H32ClCoN4O4 |
| PROTACBET结合部分2 | (S)-4-(4-chlorophenyl)-6-(2-methoxy-2-oxoethyl)-3,9-dimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-2-carboxylic acid | 916493-82-8 | C20H17ClN4O4S |
| PRL-3抑制剂 | 5-[[5-Bromo-2-[(2-bromophenyl)methoxy]phenyl]methylene]-2-thioxo-4-thiazolidinone | 893449-38-2 | C17H11Br2NO2S2 |
| PR171关键中间体IV | (S)-methyl 2-((S)-2-tert.butoxycarbonyIamino-4-phenylbutanamido-4-methylpentanamido)-3-phenylpropanoate | 868539-96-2 | C31H43N3O6 |
| PPIase-Parvulin抑制剂 | 1,3,6,8-tetrahydro-1,3,6,8-tetraoxo-benzo[lmn][3,8]phenanthroline-2,7-diacetic acid 2,7-diethyl ester | 64005-90-9 | C22H18N2O8 |
| PPG-6-山梨醇聚醚-245 | PPG-6-Sorbeth-245 | 56449-05-9 | C36H74O18 |
| PPG-2肉豆蔻醇醚丙酸酯 | PPG-2 myristyl ether propionate | 111497-87-1 | C23H46O4 |
| PPG-2甲醚 | Dipropylenglykol-monomethylether | 13429-07-7 | C7H16O3 |
| PPG-26油酸酯 | 3-hydroxypropyl (E)-octadec-9-enoate | 31394-71-5 | C21H40O3 |
| PPADS四钠盐 | Ppads | 149017-66-3 | C14H14N3O12PS2 |
| PPACKII,三氟乙酸盐 | Phenylalanyl-phenylalanyl-arginine chloromethyl ketone | 74392-49-7 | C25H33ClN6O3 |
| POSS-十二苯基 | Heptacyclo(11.11.1.13,9.15,21.17,19.111,17.115,23)dodecasiloxane, 1,3,5,7,9,11,13,15,17,19,21,23-dodecaphenyl- | 18923-59-6 | C72H60O18Si12 |
| PORCN酶活性和WNT抑制剂(WNT-C59) | 2-(4-(2-methylpyridin-4-yl)phenyl)-N-(4-(pyridin-3-yl)phenyl)acetamide | 1243243-89-1 | C25H21N3O |
| POLO-LIKEKINASE1抑制剂 | GSK461364 | 929095-18-1 | C27H28F3N5O2S |
| PND-1186游离态 | 2-(2-(2-methoxy-4-morpholinophenylamino)-5-(trifluoromethyl)pyridin-4-ylamino)-N-methylbenzamide | 1061353-68-1 | C25H26F3N5O3 |
| PNA-胸腺嘧啶单体 | 2-(N-(2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)ethyl)-2-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)acetamido)acetic acid | 169396-92-3 | C26H26N4O7 |
| PNA-胞嘧啶单体 | N-(N-Fmoc-2-aminoethyl)-N-[(N-4-Bhoc-1-cytosyl)acetyl]glycine | 186046-81-1 | C39H35N5O8 |
| PLK1抑制剂(RO3280) | RO3280 | 1062243-51-9 | C27H35F2N7O3 |
| PKR抑制剂,阴性对照 | 5-Chloro-3-[(3,5-dichloro-4-hydroxyphenyl)methylidene]-1,3-dihydro-2H-indol-2-one | 852547-30-9 | C15H8Cl3NO2 |
| PKR抑制剂(MITAPIVAT) | N-(4-(4-(cyclopropylmethyl)piperazine-1-carbonyl)phenyl)quinoline-8-sulfonamide | 1260075-17-9 | C24H26N4O3S |
| PKI-402; 1-[4-[3-乙基-7-(吗啉-4-基)-3H-[1,2,3]三唑并[4,5-d]嘧啶-5-基]苯基]-3-[4-[(4-甲基哌嗪-1-基)羰基]苯基]脲 | PKI-402 | 1173204-81-3 | C29H34N10O3 |